• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 期刊论文
  5. Potential etiopathogenesis of seventh day syndrome following living donor liver transplantation:isch

Potential etiopathogenesis of seventh day syndrome following living donor liver transplantation:isch

来源 :国际肝胆胰疾病杂志：英文版 | 被引量 : 0次 | 上传用户：wwwerroo
【摘 要】
：
BACKGROUND:Seventh-day syndrome (7DS) is an early serious complication following liver transplantation with a high mortality because of its unknown etiopathogen
【作 者】
：
Lan  Xiang Li  Bo Wang  Xiao-F 
【机 构】
：
SichuanUniv,SichuanUniv
【出 处】
：
国际肝胆胰疾病杂志：英文版
【发表日期】
：
2010年1期
【关键词】
：
seventh-day SYNDROME living DONOR liver transplantation ischemic hepatitis ETIOP 
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
BACKGROUND:Seventh-day syndrome (7DS) is an early serious complication following liver transplantation with a high mortality because of its unknown etiopathogenesis.This study aimed to analyze the potential etiopathogenesis of 7DS.METHODS:A retrospective
其他文献
Clinical management of hepatitis B virus infection correlated with liver transplantation
BACKGROUND:As a radical cure for post-hepatitis B virus (HBV)-related liver cirrhosis and hepatocellular carcinoma,liver transplantation has been applied in man
期刊
HEPATITISBVACCINATIONHEPATITISBIMMUNOGLOBULINLAMIVUDINElivertransplantat
Protective effect of probiotics on intestinal barrier function in malnourished rats after liver tran
BACKGROUND: Most patients waiting for liver transplantation have end-stage liver diseases with malnutrition, which is prone to induce intestinal barrier dysfunc
期刊
liverTRANSPLANTATIONPROBIOTICSINTESTINALMICROFLORAINTESTINALBARRIERfuncti
Fulminant liver failure models with subsequent encephalopathy in the mouse
BACKGROUND:A reliable model of fulminant liver failure (FLF) is urgently required in this research field.This study aimed to develop a murine FLF model.METHODS:
期刊
ANIMALmodelacuteliverfailureAZOXYMETHANEGALACTOSAMINEtumorNECROSISFACTO
Clinicopathological analysis of 14 patients with combined hepatocellular carcinoma and cholangiocarc
BACKGROUND:Combined hepatocellular carcinoma and cholangiocarcinoma (cHCC-CC) is an uncommon subtype of primary hepatic carcinoma,and its prognosis is poor.This
期刊
LIVERNEOPLASMSHEPATOCELLULARCARCINOMACHOLANGIOCARCINOMAPROGNOSISstemcells
Evaluation outcomes of donors in living dono liver transplantation: a single-center analysis of 132
BACKGROUND: Donor safety has always been a major concern and potential risk to the donor must be balanced against recipient benefit. However, lack of a standard
期刊
liverTRANSPLANTATIONLIVINGDONORriskFACTORSsafetyliver transplantation li
Portopulmonary hypertension and serum endothelin levels in hospitalized patients with cirrhosis
BACKGROUND:Cirrhosis is associated with several extrahepatic manifestations including portopulmonary hypertension (PPHT).Recent data suggest that endothelins (E
期刊
CIRRHOSISportopulmonaryHYPERTENSIONENDOTHELINcirrhosisportopulmonary hypert
YKL-40 expression in human hepatocellular carcinoma:a potential biomarker?
BACKGROUND:YKL-40 is a new biomarker with diagnostic value in many different cancers.Whether it may serve as a biomarker for hepatocellular carcinoma (HCC) is s
期刊
YKL-40HEPATOCELLULARCARCINOMACIRRHOSISYKL-40hepatocellular carcinomacirrho
Impact of human leukocyte antigen matching on hepatitis B virus recurrence after liver transplantati
BACKGROUND:Liver transplantation(LT)is an effective therapy for end-stage hepatitis B virus(HBV)infection. Recurrence of HBV is one of the frequent complication
期刊
livertransplantationhumanLEUKOCYTEANTIGENHEPATITISBvirusRECURRENCEliver
GPC3 fused to an alpha epitope of HBsAg acts as an immune target against hepatocellular carcinoma as
BACKGROUND:The incidence of hepatocellular carcinoma (HCC)in China is closely related to the population infected with hepatitis B virus(HBV).HCC cells with HBV
期刊
HBsAg-αepitopeGLYPICAN3hepatocellularcarcinomahepatitisBvirusproteineng
Salvianolic acid B modulates the expression of drug-metabolizing enzymes in HepG2 cells
BACKGROUND: Enzymes involved in drug and xenobiotic metabolism have been considered to exist in two groups: phase I and phase II enzymes. Cytochrome P450 isoenz
期刊
drugmetabolizingENZYMESCYP3A4CYP1A2GLUTATHIONES-TRANSFERASESHEPG2cellsS